Adipogenesis inhibitory factor. A novel inhibitory regulator of adipose conversion in bone marrow

FEBS Lett. 1991 Aug 19;288(1-2):13-6. doi: 10.1016/0014-5793(91)80991-b.

Abstract

Recombinant adipogenesis inhibitory factor (AGIF) was purified to homogeneity from the conditioned medium of COS-1 cells transfected with human AGIF cDNA. The amino-terminal sequence analysis of the mature AGIF revealed that AGIF was produced as a precursor consisting of 199 amino acids and processed into a mature form of 178 amino acids by a cleavage between Ala(-1) and Pro(+1). The purified AGIF inhibited the process of adipogenesis in mouse 3T3-L1 preadipocytes, indicating that AGIF directly acts on the cells. AGIF acted as an adipogenic antagonist not only on the extramedullary cell line 3T3-L1 but also on the mouse bone marrow stroma-derived cell line H-1/A, suggesting that this cytokine may regulate adipogenesis in bone marrow.

MeSH terms

  • Adipose Tissue / cytology*
  • Adipose Tissue / drug effects
  • Amino Acid Sequence
  • Animals
  • Blotting, Western
  • Bone Marrow / drug effects*
  • Bone Marrow / metabolism
  • Bone Marrow Cells
  • Cell Differentiation / drug effects
  • Cell Line
  • Cytokines / chemistry
  • Cytokines / isolation & purification
  • Cytokines / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Interleukin-11
  • Interleukins / chemistry
  • Interleukins / isolation & purification
  • Interleukins / pharmacology*
  • Mice
  • Molecular Sequence Data
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / pharmacology
  • Sequence Homology, Nucleic Acid

Substances

  • Cytokines
  • Interleukin-11
  • Interleukins
  • Recombinant Proteins